Vincristine

Breastfeeding
  • TRADE NAME: Vincasar (Teva)
  • INDICATIONS: Leukemias, lymphomas, neuroblastoma, Wilm's tumor
  • SYNONYM: oncovin
  • CLASS: Antimitotic, Vinca alkaloid
  • HALF-LIFE: 24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Aldesleukin, Aprepitant, Bromelain, Fluconazole, Gadobenate, Influenza Vaccine, Itraconazole, Ketoconazole, Lopinavir, Miconazole, Nifedipine, Posaconazole, Thalidomide

PREGNANCY CATEGORY: D

Our database has 98 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 01/06/2023

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top